Navigation Links
Moderate Growth in $26 Billion Respiratory Devices: Report
Date:4/3/2017

ROCKVILLE, Md., April 3, 2017 /PRNewswire/ -- Kalorama Information says that the world market for respiratory devices will experience moderate growth due to an increasing aging population and increasing respiratory diseases worldwide. Even though there is ongoing pressure to cut costs in 2017 and beyond, respiratory device growth outlook remains positive in the respiratory market, according to the market research publisher.   The market encompasses many different products to help treat and monitor respiratory conditions as well as many large and small manufacturers. Respiratory devices have grown impressively in many of the categories over last few years. Continued demand for respiratory medical equipment will likely be fueled by rising incidence of respiratory diseases such as sleep apnea, asthma, and COPD.  The bulk of the growth of the market is expected to arise from an increasing incidence of COPD worldwide and innovative products entering the market.

The size of the respiratory device market is 25.6 billion according to Kalorama's most recent report: The World Market for Respiratory Devices.

Products included in the worldwide respiratory device market are:

  • Inhalers 
  • Nebulizers
  • Airway/Mask equipment
  • Sleep apnea equipment
  • Oxygen therapy equipment and ventilators
  • Medical humidifiers
  • Respiratory measurement  and diagnostic devices

The market also will grow thanks to the shifting trend towards the use of home care products for the graying population across the globe.  The demand for respiratory devices in the United States will continue to escalate due to an aging population and prevalence of respiratory disease but will be tempered somewhat by reimbursement and cost cutting measures. In Europe, the outlook is cautious due to new European product directives but there is a drive to modernize healthcare systems in Europe. Market growth in Asia Pacific is likely to be highest in China due to higher standard of living, better healthcare and government investment in healthcare.  Brazil is expected to contribute moderate to high growth over the forecast period due to investments in healthcare infrastructure and rising awareness of respiratory diseases and treatments.   Advancements in respiratory devices along with a strong desire to maintain good health will positively influence the outlook for the world market for respiratory devices.  Kalorama's report contains figures for COPD devices and sleep apnea markets. 

Companies in respiratory devices include: 3M, Philips/Respironics, ResMed, Inc., Teleflex and Becton Dickinson, among others.  The worldwide respiratory device industry has been highly fragmented in nature. The majority of the companies in this industry excel in a few segments, such as inhalers or respiratory measurement and diagnostic devices, humidification or oxygen therapy devices. This fragmentation leads to plethora of competitors that are both regional and local in nature. Many companies have a narrow segment focus.

The World Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement) provides revenue data for the global and geographic opportunities for respiratory equipment.  The report can be found at: http://www.kaloramainformation.com/Respiratory-Devices-Inhalers-10725525/.

For more Kalorama reports on medical devices visit: https://www.kaloramainformation.com/medical-devices-market-c1126/.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.  

Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.

Press Contact:                                                        
Bruce Carlson
212 807 2262                                                         
bcarlson@marketresearch.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/moderate-growth-in-26-billion-respiratory-devices-report-300429229.html


'/>"/>
SOURCE Kalorama Information
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
2. Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
3. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
4. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
5. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
6. An Expanding Patient Pool And Technological Innovation Will Drive Moderate Growth In The US Market For Biopsy Devices
7. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
8. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
9. Olodaterol Shows Sustained Improvements in Lung Function in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
10. Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
11. Greater Efficacy on Cognition and Function Over Current Treatments Remain Neurologists Top Unmet Need in Mild to Moderate Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... LONE TREE, Colo. (PRWEB) , ... June 13, ... ... CO, is thrilled to open its doors to a wellness center dedicated to ... A. Atagi of Atagi Plastic Surgery & Skin Aesthetics, BESANA Health & Wellness ...
(Date:6/13/2019)... ... June 13, 2019 , ... IPVideo Corporation ... visual weapons detection systems, is proud to announce its verified integration with its ... verified technology partner IPVideo’s award-winning HALO sensor is now available on the Milestone ...
(Date:6/13/2019)... ... June 13, 2019 , ... The American Psychiatric Nurses Association announced ... current executive director Nicholas Croce Jr., MS. The search will be led by an ... past APNA Presidents, and Council and Chapter leaders. , The job description and more ...
Breaking Medicine Technology:
(Date:6/12/2019)... ... June 12, 2019 , ... ... relationships with caregivers and dementia patients to deteriorate. , Researchers from the ... a survey with professional caregivers who care for people who have dementia and ...
(Date:6/12/2019)... ... ... In September of 2018, NVNA and Hospice (NVNA) partnered with Health Recovery ... its full-scale launch in March, NVNA has expanded its program with HRS to provide ... has achieved an average all-cause hospital readmissions rate of 7.3% and has seen a ...
(Date:6/12/2019)... YORK (PRWEB) , ... June 12, 2019 , ... ... disability that significantly impacts their life, preventing them from participating in education or ... Project (ICP) will urge policymakers to recognize communication as a human right and ...
(Date:6/11/2019)... ... 11, 2019 , ... CareSet announced today that co-founder Ashish Patel has been ... through the TMCx Accelerator startup program and into expanded new offices located in Uptown, ... grown into a company of 18 and climbing. , “Ashish’s passion and work ...
(Date:6/6/2019)... ... June 06, 2019 , ... Dr. Eugene A. Isola III is an ... Hackensack Meridian Raritan Bay Medical Center. For Dr. Isola, dentistry is not just a ... Isola knows the importance of providing five-star services and treats his patients as if ...
Breaking Medicine News(10 mins):